Document Detail

Detection of pivaloylcarnitine in pediatric patients with hypocarnitinemia after long-term administration of pivalate-containing antibiotics.
MedLine Citation:
PMID:  20651467     Owner:  NLM     Status:  MEDLINE    
Some oral antibiotics contain a pivalate ester, because molecules with a pivalate entity show enhanced absorption in the intestine. Upon absorption, such a "prodrug" is broken down into the active form of a given antibiotic and a pivalate molecule, the latter of which is converted to pivaloylcarnitine through pivaloyl-CoA and is excreted in the urine. Long-term administration of drugs containing pivalate decreases blood carnitine level and causes defects in fatty acid oxidation. Here, we used liquid chromatography tandem mass spectrometry to measure carnitine and pivaloylcarnitine levels in two patients (Patient 1: 16-month-old boy and Patient 2: 18-month-old boy) with secondary carnitine deficiency and hypoglycemic convulsions caused by pivalate-containing antibiotics. Both patients were administered excessive doses of pivalate for the long-term treatment of recurrent infection, and consequently, the serum free carnitine levels were very low (Patient 1: 1.0 micromol/L and Patient 2: 0.4 micromol/L), compared to normal range of 33.3-43.0 micromol/l, while the serum pivaloylcarnitine levels were elevated from normally undetectable level (Patient 1: 3.7 micromol/L and Patient 2: 1.6 micromol/L). Patient 1 recovered immediately after the glucose infusion, whereas Patient 2 remained symptomatic even after blood glucose level was normalized and fully recovered after carnitine supplementation. The urine pivaloylcarnitine level in Patient 2 was increased during carnitine supplementation (from 821.4 to 12,200 micromol/g creatinine) even after discontinuing the antibiotics, indicating that a considerable amount of pivalate was accumulated in the tissues. In conclusion, long-term administration of pivalate-containing antibiotics should be avoided particularly in children.
Yoko Nakajima; Tetsuya Ito; Yasuhiro Maeda; Sayaka Ichiki; Naruji Sugiyama; Mihoko Mizuno; Yasuko Makino; Tokio Sugiura; Yukihisa Kurono; Hajime Togari
Related Documents :
3265667 - Bacteraemic haemophilus influenzae pneumonia.
17642727 - Bacteriology of diabetic foot lesions.
2928907 - Diagnostic and therapeutic approaches to pyogenic abscess of the liver.
15623957 - Isolation and characterization of candida spp. in jordanian cancer patients: prevalence...
22282247 - Renal impairment in multiple myeloma: presenting features in different departments.
6714787 - Microvascular studies in human radiation bowel disease.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Tohoku journal of experimental medicine     Volume:  221     ISSN:  1349-3329     ISO Abbreviation:  Tohoku J. Exp. Med.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-23     Completed Date:  2010-10-19     Revised Date:  2013-01-03    
Medline Journal Info:
Nlm Unique ID:  0417355     Medline TA:  Tohoku J Exp Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  309-13     Citation Subset:  IM    
Department of Pediatrics and Neonatology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / adverse effects*,  metabolism
Carnitine / analogs & derivatives*,  analysis,  blood*,  deficiency,  metabolism,  pharmacology
Cephalosporins / adverse effects*,  metabolism
Chromatography, High Pressure Liquid
Tandem Mass Spectrometry
Treatment Outcome
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Cephalosporins; 541-15-1/Carnitine; 98299-38-8/pivaloylcarnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of Sophy ?-Glucan on Immunity and Growth Performance in Broiler Chicken.
Next Document:  Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among met...